Endo International PLC

Find more results for SUSAN M. HUTSON´┐Ż

Officers and directors

Roger H. Kimmel
Independent Chairman of the Board
Rajiv De Silva
President, Chief Executive Officer, Director
Suketu P Upadhyay
Chief Financial Officer, Executive Vice President
Camille Farhat
President of American Medical Systems
Brian Lortie
President, U.S. Branded Pharmaceuticals
Susan Hall
Executive Vice President, Chief Scientific Officer, and Global Head of Research & Development and Quality
Matthew Joseph Maletta
Executive Vice President, Chief Legal Officer
Donald W. Degolyer
Chief Operating Officer, Pharmaceuticals
Craig Paterson M.D.
Chief Medical Officer
Shane M. Cooke
Independent Director


Minerva House, Simmonscourt Road
DUBLIN, 00000
+353-1-2682000 (Phone)

Website links

Endo International plc (Endo) is a global specialty healthcare company focused on branded and generic pharmaceuticals and devices. The Company operates in four segments: U.S. Branded Pharmaceuticals, U.S. Generic Pharmaceuticals, Devices and International Pharmaceuticals. U.S. Branded Pharmaceuticals segment includes brand names, such as Lidoderm, Opana ER, Voltaren Gel, Percocet, Fortesta Gel and Natesto, among others. Non-branded U.S. Generic Pharmaceuticals portfolio consists of products focused on pain management. Devices segment focuses on providing technology solutions to physicians treating women's pelvic health conditions and operates in the business lines, such as women's health therapy. International Pharmaceuticals segment includes a range of specialty pharmaceutical products and certain medical devices for the Canadian, Latin American, South African and world markets.

Related companies

* Delayed by up to 20 minutes -  Disclaimer